Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0000950170-23-049777

Chief Financial Officer sold 5,762 shares at an average $3.58 ($20,609)

From the SEC's structured data for this filing

Trades in this filing

Greenway Schond L. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-25 Sale : show line 1 in the form −1,908 $3.57 $6,812 226,123 D
2023-09-25 Sale : show line 2 in the form −3,854 $3.58 $13,797 222,269 D
Open-market sales · 5,762 sh · avg $3.58 · $20,609
Loading xslF345X05/ownership.xml…